Showing results 1 to 20 of 32
next >
| Issue Date | Title | Author(s) |
| 2023 | Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA. | Yaghoubi Naei, V; Bordhan, P; Mirakhorli, F; Khorrami, M; Shrestha, J; Nazari, H; Kulasinghe, A; Ebrahimi Warkiani, M |
| 2020-01 | Application of microfluidic technology in cancer research and therapy. | Azadi, S; Aboulkheyr Es, H; Kulasinghe, A; Bordhan, P; Ebrahimi Warkiani, M |
| 2020-11-03 | Circulating tumour cell clusters: Insights into tumour dissemination and metastasis. | Herath, S; Razavi Bazaz, S; Monkman, J; Ebrahimi Warkiani, M; Richard, D; O'Byrne, K; Kulasinghe, A |
| 2023-01-01 | Circulating Tumour Cell Isolation and Molecular Profiling; Potential Therapeutic Intervention | Radfar, P; Es, HA; Kulasinghe, A; Thiery, JP; Warkiani, ME |
| 2022 | Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update. | Kapeleris, J; Ebrahimi Warkiani, M; Kulasinghe, A; Vela, I; Kenny, L; Ladwa, R; O'Byrne, K; Punyadeera, C |
| 2018-12-01 | A Collective Route to Head and Neck Cancer Metastasis | Kulasinghe, A; Schmidt, H; Perry, C; Whitfield, B; Kenny, L; Nelson, C; Warkiani, ME; Punyadeera, C |
| 2023 | Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy. | Sadeghirad, H; Liu, N; Monkman, J; Ma, N; Cheikh, BB; Jhaveri, N; Tan, CW; Warkiani, ME; Adams, MN; Nguyen, Q; Ladwa, R; Braubach, O; O'Byrne, K; Davis, M; Hughes, BGM; Kulasinghe, A |
| 2021 | Emerging role of circulating tumor cells in immunotherapy. | Rzhevskiy, A; Kapitannikova, A; Malinina, P; Volovetsky, A; Aboulkheyr Es, H; Kulasinghe, A; Thiery, JP; Maslennikova, A; Zvyagin, AV; Ebrahimi Warkiani, M |
| 2020-10-26 | Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After The COVID-19 Pandemic. | Hanaei, S; Takian, A; Majdzadeh, R; Maboloc, CR; Grossmann, I; Gomes, O; Milosevic, M; Gupta, M; Shamshirsaz, AA; Harbi, A; Burhan, AM; Uddin, LQ; Kulasinghe, A; Lam, C-M; Ramakrishna, S; Alavi, A; Nouwen, JL; Dorigo, T; Schreiber, M; Abraham, A; Shelkovaya, N; Krysztofiak, W; Ebrahimi Warkiani, M; Sellke, F; Ogino, S; Barba, FJ; Brand, S; Vasconcelos, C; Salunke, DB; Rezaei, N |
| 2017-02-15 | Enrichment of circulating head and neck tumour cells using spiral microfluidic technology | Kulasinghe, A; Tran, THP; Blick, T; O'Byrne, K; Thompson, EW; Warkiani, ME; Nelson, C; Kenny, L; Punyadeera, C |
| 2020-10 | Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Oleary, C; Vela, I; Leo, P; Sternes, P; O'Byrne, K; Punyadeera, C |
| 2020-11-27 | High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). | Monkman, J; Taheri, T; Ebrahimi Warkiani, M; O'Leary, C; Ladwa, R; Richard, D; O'Byrne, K; Kulasinghe, A |
| 2021 | <i>IFI27</i> transcription is an early predictor for COVID-19 outcomes; a multi-cohort observational study | Shojaei, M; Shamshirian, A; Monkman, J; Grice, L; Tran, M; Tan, CW; Rossi, GR; McCulloch, T; Nalos, M; Chew, KY; Zhu, Y; Xia, Y; Wells, T; Senegaglia, AC; Rebelatto, CLK; Franck, CL; dos Santos, AFR; de Noronha, L; Motamen, S; Valadan, R; Amjadi, O; Gogna, R; Madan, E; Alizadeh-Navaei, R; Lamperti, L; Zuñiga, F; Nova-Lamperti, E; Labarca, G; Knippenberg, B; Herwanto, V; Wang, Y; Phu, A; Chew, T; Kwan, T; Kim, K; Teoh, S; Pelaia, T; Kuan, WS; Jee, Y; Iredell, J; O’Byrne, K; Fraser, J; Davis, M; Belz, G; Warkiani, M; Gallo, CS; Souza-Fonseca-Guimaraes, F; Nguyen, Q; Mclean, A; Kulasinghe, A; Short, K; Tang, B |
| 2022 | IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study. | Shojaei, M; Shamshirian, A; Monkman, J; Grice, L; Tran, M; Tan, CW; Teo, SM; Rodrigues Rossi, G; McCulloch, TR; Nalos, M; Raei, M; Razavi, A; Ghasemian, R; Gheibi, M; Roozbeh, F; Sly, PD; Spann, KM; Chew, KY; Zhu, Y; Xia, Y; Wells, TJ; Senegaglia, AC; Kuniyoshi, CL; Franck, CL; Dos Santos, AFR; de Noronha, L; Motamen, S; Valadan, R; Amjadi, O; Gogna, R; Madan, E; Alizadeh-Navaei, R; Lamperti, L; Zuñiga, F; Nova-Lamperti, E; Labarca, G; Knippenberg, B; Herwanto, V; Wang, Y; Phu, A; Chew, T; Kwan, T; Kim, K; Teoh, S; Pelaia, TM; Kuan, WS; Jee, Y; Iredell, J; O'Byrne, K; Fraser, JF; Davis, MJ; Belz, GT; Warkiani, ME; Gallo, CS; Souza-Fonseca-Guimaraes, F; Nguyen, Q; Mclean, A; Kulasinghe, A; Short, KR; Tang, B |
| 2023-02 | Immunotherapeutic targets in non-small cell lung cancer. | Sadeghirad, H; Bahrami, T; Layeghi, SM; Yousefi, H; Rezaei, M; Hosseini-Fard, SR; Radfar, P; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2024-04 | In situ characterization of the tumor microenvironment. | Sadeghirad, H; Yaghoubi Naei, V; O'Byrne, K; Warkiani, ME; Kulasinghe, A |
| 2021-06-03 | Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study | Bark, JM; Kulasinghe, A; Hartel, G; Leo, P; Warkiani, ME; Jeffree, RL; Chua, B; Day, BW; Punyadeera, C |
| 2017-05-16 | PD-L1 expressing circulating tumour cells in head and neck cancers | Kulasinghe, A; Perry, C; Kenny, L; Warkiani, ME; Nelson, C; Punyadeera, C |
| 2019-03-18 | Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets. | Kulasinghe, A; Kapeleris, J; Cooper, C; Warkiani, ME; O'Byrne, K; Punyadeera, C |
| 2018-08-14 | The prognostic role of circulating tumor cells (CTCs) in lung cancer | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Vela, I; Kenny, L; O'Byrne, K; Punyadeera, C |
